Business Context and Reporting Period
This Form 8-K, filed on April 27, 2020, by Crane Co. (the "Company"), reports the results of operations for the quarter ended March 31, 2020. The filing primarily details significant updates regarding the Company's asbestos liability estimates, claims activity, and insurance recoveries. Detailed financial results for the quarter are referenced in an attached press release (Exhibit 99.1) but are not explicitly enumerated in the text of this report.
Key Financial Metrics: Asbestos Liability and Costs
The filing provides specific data regarding asbestos-related costs and liabilities, which are material to the Company's financial condition.
- Total Asbestos Liability: $696 million as of March 31, 2020 (down from $712 million as of December 31, 2019).
- Current Portion of Liability: $65 million, representing the best estimate of costs expected to be paid within the next twelve months.
- Insurance Recovery Asset: $94 million as of March 31, 2020 (down from $98 million as of December 31, 2019).
- Costs Incurred (Q1 2020): $12.6 million total (Settlement/indemnity: $8.2 million; Defense: $4.4 million).
- Cash Payments (Q1 2020): $11.7 million net pre-tax payments (Settlement/indemnity: $11.0 million; Defense: $4.3 million; Insurance receipts: $3.6 million).
- Pending Claims: 29,162 claims as of March 31, 2020.
Material Changes Versus Prior Period
Comparing the three months ended March 31, 2020, to the same period in 2019:
- Costs Incurred: Decreased significantly from $26.5 million in Q1 2019 to $12.6 million in Q1 2020.
- Cash Payments: Increased from $9.7 million in Q1 2019 to $11.7 million in Q1 2020.
- Claims Activity: New claims filed were relatively stable (681 in Q1 2020 vs. 675 in Q1 2019), while dismissals decreased (410 in Q1 2020 vs. 858 in Q1 2019).
- Liability Estimate: The total liability decreased by $16 million from the prior quarter due to cash payments and settlements, though no change in the underlying actuarial estimate was warranted for the period ended March 31, 2020.
Outlook, Risks, and Contingencies
Liability Methodology and Forecast: The Company utilizes an independent actuarial firm to estimate liabilities through 2059. The estimate is driven by four primary factors: the number of new mesothelioma claims, average settlement costs for mesothelioma, the percentage of mesothelioma claims dismissed, and aggregate defense costs. Management determined no change to the estimate was necessary for Q1 2020 as actual experience approximated assumptions.
Insurance Coverage: The Company has settled with all but two of its solvent excess insurers. The model forecasts that approximately 14% of the total liability will be reimbursed by insurers. The Company notes that cash payments and insurance receipts may fluctuate due to timing lags and insurer payment practices.
Risks and Uncertainties: The filing highlights significant uncertainties regarding the ultimate exposure to asbestos claims. Variables include the number and severity of future claims, changes in case law, legislative solutions, and the financial viability of insurance carriers. A significant upward trend in claims or costs could materially affect the estimated liability and financial results.
Investor Verification Checklist
- Verify the detailed revenue, profit, and cash flow figures for Q1 2020 in the attached Exhibit 99.1 (Earnings Press Release), as they are not listed in this 8-K text.
- Monitor the trend of new mesothelioma claims versus dismissals, as these are the primary drivers of the liability estimate.
- Review the status of the two remaining solvent excess insurers with whom the Company has not yet finalized settlement agreements.
- Assess the impact of the $65 million current portion of the asbestos liability on near-term liquidity and cash flow projections.
- Track any legislative or judicial developments in key jurisdictions (e.g., New York, Texas, Mississippi) that could alter the types of claims proceeding to trial.